
Startup accelerator running programmes for early-stage and scaling technology founders in the North East of England

A London venture capital firm investing only in advanced therapies for high unmet medical need

4BIO Capital is a London-based venture capital firm that concentrates entirely on advanced therapies. It backs early-stage companies developing treatments where patients have few or no good options, with the stated goal of widening access to potentially curative medicines.
The firm looks for early-stage companies working on cell therapy, gene therapy, RNA treatments, targeted therapies and the microbiome. Its investor clients want exposure to this area of medicine.
Summary written by TrustList from the business's own published information, Sep 2026.
4BIO Capital is ranked on 1 TrustList ranking at #41.
Every ranking orders its listings by their reviews, how complete the profile is and the Trust Score. 4BIO Capital has no reviews yet and 3 of the 10 profile details we look for. Where no listing on a page has been reviewed, the order follows the profiles alone.
Its profile: “4BIO Capital is a London-based venture capital firm that concentrates entirely on advanced therapies.”
Of the top 64 here, 8 also cover private equity and 8 also cover partners; 23 also work in New York City and 10 also work in San Francisco.
Behind 2U (company), ahead of ABRY Partners.
As of 2026-11-01. Organic ranks only; sponsored placements are never ranks. How TrustList ranks
Used it? Your experience helps other buyers decide.
Write a reviewNo questions yet. Be the first to ask about 4BIO Capital.
Similar listings buyers compare against this one.

Startup accelerator running programmes for early-stage and scaling technology founders in the North East of England

Product discovery software for B2B and B2C sellers, covering search, guided selling and product content

Member-based investor group funding early-stage companies through monthly review and a chapter roadshow

Venture capital firm partnering with founders from first idea through to public listing

Silicon Valley venture capital firm investing from seed to growth stage across technology sectors

A UK and Ireland equity investor providing patient minority capital to growing companies
Everything here links back to the same verified catalogue. Pick your next stop.